Hormonal contraception and mental health: Results of a population-based study

Human Reproduction

Volumn 26, Issue 11, 2011, Pages 3085-3093

  Toffol, E ^a   Heikinheimo, O ^b   Koponen, P ^a   Luoto, R ^a,c   Partonen, T ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

Author keywords

LNG IUS; mental health; mood; oral contraceptive; psychological well being

Indexed keywords

LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT;

ADULT; ALCOHOLISM; ARTICLE; BECK DEPRESSION INVENTORY; BIRTH CONTROL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC INTERVIEW SCHEDULE; DISEASE ASSOCIATION; FEMALE; GENERAL HEALTH QUESTIONNAIRE; HORMONAL CONTRACEPTION; HUMAN; INFORMATION PROCESSING; IRRITABILITY; MAJOR CLINICAL STUDY; MENTAL CONCENTRATION; MENTAL DISEASE; MENTAL HEALTH; POPULATION RESEARCH; PSYCHOLOGICAL WELL BEING; RETROSPECTIVE STUDY; WAKEFULNESS;

EID: 80054888121     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/der269     Document Type: Article

References (46)

1. Archer B, Irwin D, Jensen K, Johnson ME, Rorie JA. Depot medroxyprogesterone. Management of side-effects commonly associated with its contraceptive use. J Nurse Midwifery 1997; 42:104-111. (Pubitemid 127749889)
2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
3. Beck AT, Steer RA, Carbin GM. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 1988;8:77-100. (Pubitemid 18045797)
4. Bisaga K, Petkova E, Cheng J, Davies M, Feldman JF, Whitaker AH. Menstrual functioning and psychopathology in a county-wide population of high-school girls. J Am Acad Child Adolesc Psychiatry 2002;41:1197-1204. (Pubitemid 38338039)
5. Borgström A, Odlind V, Ekselius L, Sundström-Poromaa I. Adverse mood effects of combined oral contraceptives in relation to personality traits. Eur J Obstet Gynecol Reprod Biol 2008;141:127-130.
6. Braem MG, Onland-Moret NC, van den Brandt PA, Goldbohm RA, Peeters PH, Kruitwagen RF, Schouten LJ. Reproductive and hormonal factors in association with ovarian cancer in the Netherlands Cohort Study. Am J Epidemiol 2010;172:1181-1189.
7. Civic D, Scholes D, Ichikawa L, LaCroix AZ, Yoshida CK, Ott SM, Barlow WE. Depressive symptoms in users and non-users of depot medroxyprogesterone acetate. Contraception 2000;61:385-390. (Pubitemid 30665814)
8. Daud S, Ewies AA. Levonorgestrel-releasing intrauterine system: why do some women dislike it? Gynecol Endocrinol 2008;24:686-690.
9. Duke JM, Sibbritt DW, Young AF. Is there an association between the use of oral contraception and depressive symptoms in young Australian women?. Contraception 2007;75:27-31. (Pubitemid 44856722)
10. Ewies AA. Levonorgestrel-releasing intrauterine system-the discontinuing story. Gynecol Endocrinol 2009;25:668-673.
11. Genazzani AR, Pluchino N, Luisi S, Luisi M. Estrogen, cognition and female aging. Hum Reprod Update 2007;13:175-187.
12. Goldberg DP. The detection of psychiatric illness by questionnaire. Maudsley Monograph No 21. Oxford University Press, London, UK, 1972.
13. Goldberg DP, Rickels K, Downing R, Hesbacher P. A comparison of two psychiatric screening tests. Br J Psychiatry 1976;129:61-67.
14. Graham CA, Bancroft J, Doll HA, Greco T, Tanner A. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology 2007; 32:246-255. (Pubitemid 46420398)
15. Heistaro S. Methodology report. Health 2000 survey. Publications of National Public Health Institute, Series B 26/2008, 2008.
16. Herzberg BN, Draper KC, Johnson AL, Nicol GL. Oral contraceptives, depression and libido. BMJ 1971;3:495-500.
17. Inki P. Long-term use of the levonorgestrel-releasing intrauterine system. Contraception 2007;75:S161-S166. (Pubitemid 46770701)
18. King AR, Hunter PJ. Alcohol elimination at low blood concentrations among women taking combined oral contraceptives. J Stud Alcohol 2005;66:738-744. (Pubitemid 41688796)
19. Koponen P, Luoto R. Lisääntymisterveys Suomessa-Terveys 2000-tutkimus. B5/2004.
20. Krings KM, Matteson KA, Allsworth JE, Mathias E, Peipert JF. Contraceptive choice: how do oral contraceptive users differ from condom users and women who use no contraception? Am J Obstet Gynecol 2008;198:e46-e47.
21. Kuehner C. Gender differences in unipolar depression: an update of epidemiological findings and possible explanations. Acta Psychiatr Scand 2003;108:163-174. (Pubitemid 36963066)
22. La Vecchia C, Decarli A, Parazzini F, Gentile A, Negri E, Franceschi S. Determinants of oral contraceptive use in northern Italy. Contraception 1986;34:135-146.
23. Luukkainen T, Lähteenmäki P, Toivonen J. Levonorgestrel- releasing intrauterine device. Ann Med 1990;22:85-90. (Pubitemid 20193529)
24. Luukkainen T. Levonorgestrel-releasing intrauterine device. Ann NY Acad Sci 1991;626:43-49.
25. Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine systems. Semin Reprod Med 2001;19:355-363. (Pubitemid 34028423)
26. Maes M, Claes M, Schotte C, Delbeke L, Jacquemyn Y, Verkerk R, De Meester I, Scharpé S. Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy. J Psychosom Res 1992;36:191-197.
27. Maia H Jr, Casoy J. Non-contraceptive health benefits of oral contraceptives. Eur J Contracept Reprod Health Care 2008;13: 17-24. (Pubitemid 351271845)
28. O'Connell K, Davis AR, Kerns J. Oral contraceptives: side effects and depression in adolescent girls. Contraception 2007;75:299-304. (Pubitemid 46385916)
29. Oinonen KA, Mazmanian D. To what extent do oral contraceptives influence mood and affect? J Affect Disord 2002;70:229-240. (Pubitemid 34786641)
30. Parazzini F, Negri E, Ricci E, Franceschi S, La Vecchia C. Correlates of oral contraceptive use in Italian women, 1991-93. Contraception 1996; 54:101-106. (Pubitemid 26256712)
31. Pigott TA. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 1999;60:4-15. (Pubitemid 29431907)
32. Pluchino N, Cubeddu A, Giannini A, Merlini S, Cela V, Angioni S, Genazzani AR. Progesterone and brain: an update. Maturitas 2009; 62:349-355.
33. Raine T, Minnis AM, Padian NS. Determinants of contraceptive method among young women at risk for unintended pregnancy and sexually transmitted infections. Contraception 2003;68:19-25. (Pubitemid 37271986)
34. Raitasalo R. Elämänhallinta sosiaalipolitiikan tavoitteena. Sosiaali-ja terveysturvan tutkimuksia I. [Life Control as a Socio-Political Objective. Social Insurance Institution of Finland. Social and Health Security Research 1]. Helsinki: Kansaneläkelaitos, 1995.
35. Rapkin AJ, Morgan M, Sogliano C, Biggio G, Concas A. Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes. Fertil Steril 2006a;85:1371-1378.
36. Rapkin AJ, Biggio G, Concas A. Oral contraceptives and neuroactive steroids. Pharmacol Biochem Behav 2006b;84:628-634. (Pubitemid 350061231)
37. Rönnerdag M, Odlind V. Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. Acta Obstet Gynecol Scand 1999;78:716-721. (Pubitemid 29392677)
38. Rubinow DR, Schmidt PJ. The neuroendocrinology of menstrual cycle mood disorders. Ann N Y Acad Sci 1995;771:648-659. (Pubitemid 26077442)
39. Rubinow DR, Schmidt PJ, Roca CA. Estrogen-serotonin interactions: implications for affective regulation. Biol Psychiatry 1998;44:839-850. (Pubitemid 28520222)
40. Seedat S, Scott KM, Angermeyer MC, Berglund P, Bromet EJ, Brugha TS, Demyttenaere K, de Girolamo G, Haro JM, Jin R et al. Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Arch Gen Psychiatry 2009;66:185-195.
41. Segebladh B, Borgström A, Odlind V, Bixo M, Sundström-Poromaa I. Prevalence of psychiatric disorders and premenstrual dysphoric symptoms in patients with experience of adverse mood during treatment with combined oral contraceptives. Contraception 2009; 79:50-55.
42. Skrzypulec V, Drosdzol A. Evaluation of quality of life and sexual functioning of women using levonorgestrel-releasing intrauterine contraceptive system-Mirena. Coll Antropol 2008;32:1059-1068.
43. Warnet JM, Papoz L, Pequignot G, Eschwege E, Claude JR, Schwartz D. Alcohol consumption in healthy women: relationship to gamma-glutamyl transferase activity, mean corpuscular volume and hormonal status. Can J Public Health 1984;75:285-288. (Pubitemid 14001307)
44. Westhoff C, Truman C, Kalmuss D, Cushman L, Davidson A, Rulin M, Heartwell S. Depressive symptoms and Depo-Proveraw. Contraception 1998a;57:237-240.
45. Westhoff C, Truman C, Kalmuss D, Cushman L, Rulin M, Heartwell S, Davidson A. Depressive symptoms and Norplantw contraceptive implants. Contraception 1998b;57:241-245. (Pubitemid 28280912)
46. Wittchen HU, Lachner G, Wunderlich U, Pfister H. Test-retest reliability of the computerized DSM-IV version of the Munich-Composite International Diagnostic Interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 1998;33:568-578.